HIVE Blockchain Technologies (NASDAQ:HIVE) Stock Rating Lowered by TheStreet – MarketBeat
Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
HIVE Blockchain Technologies (NASDAQ:HIVE – Get Rating) was downgraded by TheStreet from a “c” rating to a “d+” rating in a research note issued on Thursday, TheStreetRatingsTable reports.
A number of other research analysts have also weighed in on HIVE. Canaccord Genuity Group raised their target price on HIVE Blockchain Technologies from $5.50 to $7.00 and gave the company a “buy” rating in a report on Monday, August 29th. Canaccord Genuity Group lifted their price objective on shares of HIVE Blockchain Technologies from $5.50 to $7.00 in a report on Monday, August 29th. Finally, HC Wainwright raised their price target on shares of HIVE Blockchain Technologies from $6.00 to $7.00 and gave the company a “buy” rating in a research report on Thursday, August 18th.
HIVE Blockchain Technologies Stock Performance
NASDAQ HIVE opened at $4.79 on Thursday. The company has a market cap of $393.97 million and a P/E ratio of 95.80. The company has a fifty day simple moving average of $4.45 and a 200 day simple moving average of $6.40. The company has a current ratio of 3.11, a quick ratio of 3.11 and a debt-to-equity ratio of 0.11. HIVE Blockchain Technologies has a 12-month low of $2.82 and a 12-month high of $28.00.
HIVE Blockchain Technologies (NASDAQ:HIVE – Get Rating) last issued its quarterly earnings data on Wednesday, July 20th. The company reported ($0.24) earnings per share (EPS) for the quarter. HIVE Blockchain Technologies had a net margin of 0.57% and a negative return on equity of 0.25%. The business had revenue of $49.78 million for the quarter. Sell-side analysts predict that HIVE Blockchain Technologies will post -1.24 earnings per share for the current fiscal year.
Institutional Investors Weigh In On HIVE Blockchain Technologies
An institutional investor recently bought a new position in HIVE Blockchain Technologies stock. State Street Corp purchased a new position in shares of HIVE Blockchain Technologies Ltd. (NASDAQ:HIVE – Get Rating) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 336,731 shares of the company’s stock, valued at approximately $1,007,000. State Street Corp owned about 0.41% of HIVE Blockchain Technologies as of its most recent SEC filing. Hedge funds and other institutional investors own 8.08% of the company’s stock.
HIVE Blockchain Technologies Company Profile
(Get Rating)
HIVE Blockchain Technologies Ltd. operates as a cryptocurrency mining company in Canada, Sweden, and Iceland. It engages in the mining and sale of digital currencies, including Ethereum, Ethereum Classic, and Bitcoin. The company was formerly known as Leeta Gold Corp. and changed its name to HIVE Blockchain Technologies Ltd.
Read More
- Get a free copy of the StockNews.com research report on HIVE Blockchain Technologies (HIVE)
- Could Snap Stock Rebound As Management Restructures?
- MarketBeat: Week in Review 8/29 – 9/2
- Hormel Looks Cheap At These Levels
- Lululemon Set To Soar Into September
- Could Nike Stock be Oversold, but Still Overvalued?
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider HIVE Blockchain Technologies, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and HIVE Blockchain Technologies wasn’t on the list.
While HIVE Blockchain Technologies currently has a “Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Complete the form below to receive the latest headlines and analysts’ recommendations for your stocks with our free daily email newsletter:
Tom remains optimistic about investors’ prospects going forward, even as the market reacts to the words of Fed Chair Jerome Powell about “pain ahead.”
Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat’s trending stocks report.
Identify stocks that meet your criteria using seven unique stock screeners. See what’s happening in the market right now with MarketBeat’s real-time news feed. Export data to Excel for your own analysis.
MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.
Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.
Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.
As Featured By:
MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.
Twitter Facebook StockTwits Financial Juice YouTube
© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.
Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds
© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided ‘as-is’ and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart’s disclaimer.